185 related articles for article (PubMed ID: 25522735)
1. Cortical phase changes measured using 7-T MRI in subjects with subjective cognitive impairment, and their association with cognitive function.
van Rooden S; Buijs M; van Vliet ME; Versluis MJ; Webb AG; Oleksik AM; van de Wiel L; Middelkoop HA; Blauw GJ; Weverling-Rynsburger AW; Goos JD; van der Flier WM; Koene T; Scheltens P; Barkhof F; van de Rest O; Slagboom PE; van Buchem MA; van der Grond J
NMR Biomed; 2016 Sep; 29(9):1289-94. PubMed ID: 25522735
[TBL] [Abstract][Full Text] [Related]
2. Discriminative Power of Arterial Spin Labeling Magnetic Resonance Imaging and 18F-Fluorodeoxyglucose Positron Emission Tomography Changes for Amyloid-β-Positive Subjects in the Alzheimer's Disease Continuum.
Tosun D; Schuff N; Jagust W; Weiner MW;
Neurodegener Dis; 2016; 16(1-2):87-94. PubMed ID: 26560336
[TBL] [Abstract][Full Text] [Related]
3. Basal forebrain atrophy correlates with amyloid β burden in Alzheimer's disease.
Kerbler GM; Fripp J; Rowe CC; Villemagne VL; Salvado O; Rose S; Coulson EJ;
Neuroimage Clin; 2015; 7():105-13. PubMed ID: 25610772
[TBL] [Abstract][Full Text] [Related]
4. Pre-trained MRI-based Alzheimer's disease classification models to classify memory clinic patients.
de Vos F; Schouten TM; Koini M; Bouts MJRJ; Feis RA; Lechner A; Schmidt R; van Buchem MA; Verhey FRJ; Olde Rikkert MGM; Scheltens P; de Rooij M; van der Grond J; Rombouts SARB
Neuroimage Clin; 2020; 27():102303. PubMed ID: 32554321
[TBL] [Abstract][Full Text] [Related]
5. Imaging characteristic of dual-phase (18)F-florbetapir (AV-45/Amyvid) PET for the concomitant detection of perfusion deficits and beta-amyloid deposition in Alzheimer's disease and mild cognitive impairment.
Lin KJ; Hsiao IT; Hsu JL; Huang CC; Huang KL; Hsieh CJ; Wey SP; Yen TC
Eur J Nucl Med Mol Imaging; 2016 Jul; 43(7):1304-14. PubMed ID: 27003417
[TBL] [Abstract][Full Text] [Related]
6. Comparison of imaging biomarkers for Alzheimer's disease: amyloid imaging with [18F]florbetapir positron emission tomography and magnetic resonance imaging voxel-based analysis for entorhinal cortex atrophy.
Tateno A; Sakayori T; Kawashima Y; Higuchi M; Suhara T; Mizumura S; Mintun MA; Skovronsky DM; Honjo K; Ishihara K; Kumita S; Suzuki H; Okubo Y
Int J Geriatr Psychiatry; 2015 May; 30(5):505-13. PubMed ID: 25043833
[TBL] [Abstract][Full Text] [Related]
7. The association between intra- and juxta-cortical pathology and cognitive impairment in multiple sclerosis by quantitative T
Louapre C; Govindarajan ST; Giannì C; Madigan N; Nielsen AS; Sloane JA; Kinkel RP; Mainero C
Neuroimage Clin; 2016; 12():879-886. PubMed ID: 27872810
[TBL] [Abstract][Full Text] [Related]
8. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO
J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038
[TBL] [Abstract][Full Text] [Related]
9. [Subjective cognitive impairment and Alzheimer's disease: a two year follow up of 51 subjects during two years].
Sambuchi N; Muraccioli I; Alescio-Lautier B; Paban V; Sambuc R; Jouve É; Geda YE; Petersen RK; Michel BF
Geriatr Psychol Neuropsychiatr Vieil; 2015 Dec; 13(4):462-71. PubMed ID: 26707564
[TBL] [Abstract][Full Text] [Related]
10. Cortical phase changes in Alzheimer's disease at 7T MRI: a novel imaging marker.
van Rooden S; Versluis MJ; Liem MK; Milles J; Maier AB; Oleksik AM; Webb AG; van Buchem MA; van der Grond J
Alzheimers Dement; 2014 Jan; 10(1):e19-26. PubMed ID: 23712002
[TBL] [Abstract][Full Text] [Related]
11. Reduced Cerebral Blood Flow in Mild Cognitive Impairment Assessed Using Phase-Contrast MRI.
de Eulate RG; Goñi I; Galiano A; Vidorreta M; Recio M; Riverol M; Zubieta JL; Fernández-Seara MA
J Alzheimers Dis; 2017; 58(2):585-595. PubMed ID: 28453476
[TBL] [Abstract][Full Text] [Related]
12. Feasibility and acceptance of simultaneous amyloid PET/MRI.
Schütz L; Lobsien D; Fritzsch D; Tiepolt S; Werner P; Schroeter ML; Berrouschot J; Saur D; Hesse S; Jochimsen T; Rullmann M; Sattler B; Patt M; Gertz HJ; Villringer A; Claßen J; Hoffmann KT; Sabri O; Barthel H
Eur J Nucl Med Mol Imaging; 2016 Nov; 43(12):2236-2243. PubMed ID: 27435367
[TBL] [Abstract][Full Text] [Related]
13. Fully Automatic MRI-Based Hippocampus Volumetry Using FSL-FIRST: Intra-Scanner Test-Retest Stability, Inter-Field Strength Variability, and Performance as Enrichment Biomarker for Clinical Trials Using Prodromal Target Populations at Risk for Alzheimer's Disease.
Cavedo E; Suppa P; Lange C; Opfer R; Lista S; Galluzzi S; Schwarz AJ; Spies L; Buchert R; Hampel H; ;
J Alzheimers Dis; 2017; 60(1):151-164. PubMed ID: 28777748
[TBL] [Abstract][Full Text] [Related]
14. Neurobiological correlates of depressive symptoms in people with subjective and mild cognitive impairment.
Auning E; Selnes P; Grambaite R; Šaltytė Benth J; Haram A; Løvli Stav A; Bjørnerud A; Hessen E; Hol PK; Muftuler løndalen A; Fladby T; Aarsland D
Acta Psychiatr Scand; 2015 Feb; 131(2):139-47. PubMed ID: 25346330
[TBL] [Abstract][Full Text] [Related]
15. Motor cortex hypointensity on susceptibility-weighted imaging: a potential imaging marker of iron accumulation in patients with cognitive impairment.
Park M; Moon Y; Han SH; Moon WJ
Neuroradiology; 2019 Jun; 61(6):675-683. PubMed ID: 30693411
[TBL] [Abstract][Full Text] [Related]
16. Relation between subcortical grey matter atrophy and conversion from mild cognitive impairment to Alzheimer's disease.
Yi HA; Möller C; Dieleman N; Bouwman FH; Barkhof F; Scheltens P; van der Flier WM; Vrenken H
J Neurol Neurosurg Psychiatry; 2016 Apr; 87(4):425-32. PubMed ID: 25904810
[TBL] [Abstract][Full Text] [Related]
17. Cognitive and neuroimaging profiles in mild cognitive impairment and Alzheimer's disease: data from the Spanish Multicenter Normative Studies (NEURONORMA Project).
Sánchez-Benavides G; Peña-Casanova J; Casals-Coll M; Gramunt N; Molinuevo JL; Gómez-Ansón B; Aguilar M; Robles A; Antúnez C; Martínez-Parra C; Frank-García A; Fernández-Martínez M; Blesa R;
J Alzheimers Dis; 2014; 41(3):887-901. PubMed ID: 24718100
[TBL] [Abstract][Full Text] [Related]
18. Hippocampal volume change measurement: quantitative assessment of the reproducibility of expert manual outlining and the automated methods FreeSurfer and FIRST.
Mulder ER; de Jong RA; Knol DL; van Schijndel RA; Cover KS; Visser PJ; Barkhof F; Vrenken H;
Neuroimage; 2014 May; 92():169-81. PubMed ID: 24521851
[TBL] [Abstract][Full Text] [Related]
19. Comparison of cortical thickness in patients with early-stage versus late-stage amnestic mild cognitive impairment.
Ye BS; Seo SW; Yang JJ; Kim HJ; Kim YJ; Yoon CW; Cho H; Noh Y; Kim GH; Chin J; Kim JH; Jeon S; Lee JM; Na DL
Eur J Neurol; 2014; 21(1):86-92. PubMed ID: 24033766
[TBL] [Abstract][Full Text] [Related]
20. Rey's Auditory Verbal Learning Test scores can be predicted from whole brain MRI in Alzheimer's disease.
Moradi E; Hallikainen I; Hänninen T; Tohka J;
Neuroimage Clin; 2017; 13():415-427. PubMed ID: 28116234
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
